Decoding BCL6 Inhibitors: Computational Insights into the Impact of Water Networks on Potency

Water molecules in the binding site can have a critical role in small molecule binding to proteins and are an important consideration in structure-based drug design. Water networks have additional complexity as displacing one water molecule has subsequent effects on the remaining network. Modification of a lead compound that disrupts a water network can have beneficial or detrimental impacts on potency and this outcome is impossible to determine experimentally without time-consuming synthesis of the new compound. Computational methods are ideally suited to study the interplay between ligand optimization and water displacement by predicting the effect of structural changes on both the activity of the compound and the stability of neighboring water molecules. We used Grand Canonical Monte Carlo (GCMC) simulations and alchemical free energy calculations to retrospectively study a series of B-cell Lymphoma 6 (BCL6) inhibitors that sequentially displaced water molecules from a network. The methods were used to rationalize the structure-activity relationship of the compounds by quantifying the individual contributions to the binding affinity from the changes in the water network and new interactions with the protein. GCMC simulations are well-suited for studying water networks in the binding site and were able to reproduce 94% of the experimentally observed water sites from the crystal structures in a subpocket of BCL6. Using the BCL6 project as an example, we show the power of these computational methods to study water networks and how they can provide insights that are able to guide drug discovery projects.

Authors

Institutions

Publication Details

Journal
Journal of Chemical Information and Modeling
Published
2025-08-28
DOI
https://doi.org/10.1021/acs.jcim.5c01188
Citations
1
Primary Topic
Computational Drug Discovery Methods
Type
article
Field-Weighted Citation Impact
1.50

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Decoding BCL6 Inhibitors: Computational Insights into the Impact of Water Networks on Potency

Michael S. Bodnarchuk, Swen Hoelder, Andrea Scarpino, Daniella E. Hares
1 citations
Journal of Chemical Information and Modeling
Computational Drug Discovery Methods
1.50
article

Decoding BCL6 Inhibitors: Computational Insights into the Impact of Water Networks on Potency

Michael S. Bodnarchuk, Swen Hoelder, Andrea Scarpino, Daniella E. Hares
article en
1 citations

Abstract

Water molecules in the binding site can have a critical role in small molecule binding to proteins and are an important consideration in structure-based drug design. Water networks have additional complexity as displacing one water molecule has subsequent effects on the remaining network. Modification of a lead compound that disrupts a water network can have beneficial or detrimental impacts on potency and this outcome is impossible to determine experimentally without time-consuming synthesis of the new compound. Computational methods are ideally suited to study the interplay between ligand optimization and water displacement by predicting the effect of structural changes on both the activity of the compound and the stability of neighboring water molecules. We used Grand Canonical Monte Carlo (GCMC) simulations and alchemical free energy calculations to retrospectively study a series of B-cell Lymphoma 6 (BCL6) inhibitors that sequentially displaced water molecules from a network. The methods were used to rationalize the structure-activity relationship of the compounds by quantifying the individual contributions to the binding affinity from the changes in the water network and new interactions with the protein. GCMC simulations are well-suited for studying water networks in the binding site and were able to reproduce 94% of the experimentally observed water sites from the crystal structures in a subpocket of BCL6. Using the BCL6 project as an example, we show the power of these computational methods to study water networks and how they can provide insights that are able to guide drug discovery projects.

Journal of Chemical Information and ModelingVol. 65(18)
Institute of Cancer Research (GB), Discovery Centre (CA), Boston Biomedical (United States) (US), Institute of Cancer Research (CA), AstraZeneca (Singapore) (SG), AstraZeneca (Poland) (PL)
AstraZeneca, Medical Research Council
Openalex Percentile: Top 14%
Computational Drug Discovery Methods
1.50
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.